COPD Research Studies are enrolling now!
Those who qualify may receive*:
Plus, no cost to you.
No health insurance or referral needed.
All trial participants will be screened for COVID-19.
Chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema, is a long-term lung disease that makes it hard for you to breathe.
COPD can get worse over time, leading to disability and even death. More than 15 Million Americans live with COPD and it is estimated another 24 Million live with undiagnosed COPD. 210 Million people worldwide have COPD.
The symptoms include shortness of breath, a chronic cough often with a lot of mucus, frequent respiratory infections, fatigue, and wheezing. While many people with COPD get used to these symptoms as “typical” of their condition, you may experience a worsening of your symptoms called an exacerbation or flare-up. Severe flareups can result in hospitalization.
85 to 90 percent of all COPD cases are caused by cigarette smoking. But you can develop COPD even if you've quit smoking or have been exposed to secondhand smoke, chemicals, gases, air pollution, and dust – a higher risk for certain occupations.
COPD can be treated, but some people still experience flareups despite stable therapy. More research is needed so better treatment options can be available for people with COPD in the future.
Take the next step to see if you qualify for local research studies for people with COPD. But don’t delay — space is limited!
Ready to get started?
Click Here.Tell us a little bit about yourself
Answer some questions about your health
We will connect you to available studies in your area
AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.